{"count": 26, "results": [{"_id": "33220275", "pmid": 33220275, "title": "Metformin reduces proteinuria in spontaneously hypertensive rats by activating the HIF-2alpha-VEGF-A pathway.", "journal": "Eur J Pharmacol", "authors": ["Liu T", "Hong L", "Yang Y", "Qiao X", "Cai W", "Zhong M", "Wang M", "Zheng Z", "Fu Y"], "date": "2021-01-15T00:00:00Z", "doi": "10.1016/j.ejphar.2020.173731", "meta_date_publication": "2021 Jan 15", "meta_volume": "891", "meta_issue": "", "meta_pages": "173731", "score": 50260.086, "text_hl": "We determined the role of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @<m>DISEASE_Proteinuria</m> @DISEASE_MESH:D011507 @@@proteinuria@@@ and investigated the mechanism. ", "citations": {"NLM": "Liu T, Hong L, Yang Y, Qiao X, Cai W, Zhong M, Wang M, Zheng Z, Fu Y. Metformin reduces proteinuria in spontaneously hypertensive rats by activating the HIF-2alpha-VEGF-A pathway. Eur J Pharmacol. 2021 Jan 15;891():173731. PMID: 33220275", "BibTeX": "@article{33220275, title={Metformin reduces proteinuria in spontaneously hypertensive rats by activating the HIF-2alpha-VEGF-A pathway.}, author={Liu T and Hong L and Yang Y and Qiao X and Cai W and Zhong M and Wang M and Zheng Z and Fu Y}, journal={Eur J Pharmacol}, volume={891}, pages={173731}}"}}, {"_id": "33782421", "pmid": 33782421, "pmcid": "PMC8007696", "title": "Metformin ameliorates the severity of experimental Alport syndrome", "journal": "Sci Rep", "authors": ["Omachi K", "Kaseda S", "Yokota T", "Kamura M", "Teramoto K", "Kuwazuru J", "Kojima H", "Nohara H", "Koyama K", "Ohtsuki S", "Misumi S", "Takeo T", "Nakagata N", "Li JD", "Shuto T", "Suico MA", "Miner JH", "Kai H"], "date": "2021-03-29T00:00:00Z", "doi": "10.1038/s41598-021-86109-1", "meta_date_publication": "2021 Mar 29", "meta_volume": "11", "meta_issue": "1", "meta_pages": "7053", "score": 50257.824, "text_hl": "Although @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@losartan@@@ was more suppressive on @<m>DISEASE_Proteinuria</m> @DISEASE_MESH:D011507 @@@proteinuria@@@ than @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ also significantly reduced @<m>DISEASE_Proteinuria</m> @DISEASE_MESH:D011507 @@@proteinuria@@@. ", "citations": {"NLM": "Omachi K, Kaseda S, Yokota T, Kamura M, Teramoto K, Kuwazuru J, Kojima H, Nohara H, Koyama K, Ohtsuki S, Misumi S, Takeo T, Nakagata N, Li JD, Shuto T, Suico MA, Miner JH, Kai H. Metformin ameliorates the severity of experimental Alport syndrome Sci Rep. 2021 Mar 29;11(1):7053. PMID: 33782421", "BibTeX": "@article{33782421, title={Metformin ameliorates the severity of experimental Alport syndrome}, author={Omachi K and Kaseda S and Yokota T and Kamura M and Teramoto K and Kuwazuru J and Kojima H and Nohara H and Koyama K and Ohtsuki S and Misumi S and Takeo T and Nakagata N and Li JD and Shuto T and Suico MA and Miner JH and Kai H}, journal={Sci Rep}, volume={11}, number={1}, pages={7053}}"}}, {"_id": "38235867", "pmid": 38235867, "title": "Prevalence of proteinuria and its associated factors in hypertensive diabetic patients.", "journal": "Eur Rev Med Pharmacol Sci", "authors": ["Jarab AS", "Al-Qerem W", "Alzoubi KH", "Alqudah S", "Abu Heshmeh SR", "Mukattash T", "Al-Azzam S", "Naser YA", "Alkhatatbeh M"], "date": "2024-01-01T00:00:00Z", "doi": "10.26355/eurrev_202401_34901", "meta_date_publication": "2024 Jan", "meta_volume": "28", "meta_issue": "1", "meta_pages": "155-162", "score": 50254.566, "text_hl": "In contrast to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (OR=0.237; 95% CI: 0.098-0.572; p<0.01), @SPECIES_9606 @@@patients@@@ who received @GENE_INS @GENE_3630 @@@insulin@@@ (OR=1.992; 95% CI: 1.136-3.492; p<0.05), @CHEMICAL_Thiazides @CHEMICAL_MESH:D049971 @@@thiazide@@@ diuretics (OR=1.848; 95% CI: 1.108-3.083; p<0.05), calcium channel blockers (OR=1.833, 95% CI: 1.110-3.028, p<0.05), or beta-blockers (BBs) (OR=2.199, 95% CI: 1.257-3.848, p<0.01) had a higher likelihood of having @<m>DISEASE_Proteinuria</m> @DISEASE_MESH:D011507 @@@proteinuria@@@. ", "citations": {"NLM": "Jarab AS, Al-Qerem W, Alzoubi KH, Alqudah S, Abu Heshmeh SR, Mukattash T, Al-Azzam S, Naser YA, Alkhatatbeh M. Prevalence of proteinuria and its associated factors in hypertensive diabetic patients. Eur Rev Med Pharmacol Sci. 2024 Jan;28(1):155-162. PMID: 38235867", "BibTeX": "@article{38235867, title={Prevalence of proteinuria and its associated factors in hypertensive diabetic patients.}, author={Jarab AS and Al-Qerem W and Alzoubi KH and Alqudah S and Abu Heshmeh SR and Mukattash T and Al-Azzam S and Naser YA and Alkhatatbeh M}, journal={Eur Rev Med Pharmacol Sci}, volume={28}, number={1}, pages={155-162}}"}}, {"_id": "39351873", "pmid": 39351873, "title": "The effects of metformin on inflammation and apoptosis in rats with preeclampsia.", "journal": "J Hypertens", "authors": ["Chen Y", "Gao Z", "Wang L", "Duan R", "Hao H", "Jia R", "Ma H", "Gao R", "Su M", "Yang H", "Tu Z"], "date": "2024-10-02T00:00:00Z", "doi": "10.1097/HJH.0000000000003892", "meta_date_publication": "2024 Oct 2", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50253.203, "text_hl": "RESULTS: Treatment with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MET@@@ in @DISEASE_Pre_Eclampsia @DISEASE_MESH:D011225 @@@PE@@@ @SPECIES_10116 @@@rats@@@ ameliorated @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ and @<m>DISEASE_Proteinuria</m> @DISEASE_MESH:D011507 @@@proteinuria@@@, altered the expression of @DISEASE_Pre_Eclampsia @DISEASE_MESH:D011225 @@@PE@@@ biomarkers, and significantly inhibited @CHEMICAL_NG_Nitroarginine_Methyl_Ester @CHEMICAL_MESH:D019331 @@@L-NAME@@@-induced @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammation@@@ and cell apoptosis. ", "citations": {"NLM": "Chen Y, Gao Z, Wang L, Duan R, Hao H, Jia R, Ma H, Gao R, Su M, Yang H, Tu Z. The effects of metformin on inflammation and apoptosis in rats with preeclampsia. J Hypertens. 2024 Oct 2;():. PMID: 39351873", "BibTeX": "@article{39351873, title={The effects of metformin on inflammation and apoptosis in rats with preeclampsia.}, author={Chen Y and Gao Z and Wang L and Duan R and Hao H and Jia R and Ma H and Gao R and Su M and Yang H and Tu Z}, journal={J Hypertens}}"}}, {"_id": "40343634", "pmid": 40343634, "title": "Metformin attenuates endoplasmic reticulum stress in diabetic kidney disease: mechanistic insights and future perspectives.", "journal": "Int Urol Nephrol", "authors": ["Bin H", "Wen W"], "date": "2025-05-09T00:00:00Z", "doi": "10.1007/s11255-025-04562-7", "meta_date_publication": "2025 May 9", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50252.086, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ attenuates endoplasmic reticulum stress in @DISEASE_Diabetic_Nephropathies @DISEASE_MESH:D003928 @@@diabetic kidney disease@@@: mechanistic insights and future perspectives.", "citations": {"NLM": "Bin H, Wen W. Metformin attenuates endoplasmic reticulum stress in diabetic kidney disease: mechanistic insights and future perspectives. Int Urol Nephrol. 2025 May 9;():. PMID: 40343634", "BibTeX": "@article{40343634, title={Metformin attenuates endoplasmic reticulum stress in diabetic kidney disease: mechanistic insights and future perspectives.}, author={Bin H and Wen W}, journal={Int Urol Nephrol}}"}}, {"_id": "39550868", "pmid": 39550868, "title": "Protective effect of metformin on the NG-nitro-l-arginine methyl ester (l-NAME)-induced rat models of preeclampsia.", "journal": "Biochem Biophys Res Commun", "authors": ["Hao H", "Li F", "Wang F", "Ran J", "Chen Y", "Yang L", "Ma H", "Wang J", "Yang H"], "date": "2024-11-13T00:00:00Z", "doi": "10.1016/j.bbrc.2024.150996", "meta_date_publication": "2024 Nov 13", "meta_volume": "739", "meta_issue": "", "meta_pages": "150996", "score": 50249.832, "text_hl": "RESULTS: The study findings demonstrate that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MET@@@ administration improves blood pressure and 24-h @<m>DISEASE_Proteinuria</m> @DISEASE_MESH:D011507 @@@proteinuria@@@, alleviates fetal @DISEASE_Fetal_Growth_Retardation @DISEASE_MESH:D005317 @@@growth restriction@@@, ameliorate @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammation@@@ cytokines, and restores the balance of angiogenic factors and endothelial function. ", "citations": {"NLM": "Hao H, Li F, Wang F, Ran J, Chen Y, Yang L, Ma H, Wang J, Yang H. Protective effect of metformin on the NG-nitro-l-arginine methyl ester (l-NAME)-induced rat models of preeclampsia. Biochem Biophys Res Commun. 2024 Nov 13;739():150996. PMID: 39550868", "BibTeX": "@article{39550868, title={Protective effect of metformin on the NG-nitro-l-arginine methyl ester (l-NAME)-induced rat models of preeclampsia.}, author={Hao H and Li F and Wang F and Ran J and Chen Y and Yang L and Ma H and Wang J and Yang H}, journal={Biochem Biophys Res Commun}, volume={739}, pages={150996}}"}}, {"_id": "40352872", "pmid": 40352872, "title": "Metformin Versus Standard of Care in Patients with Autosomal Dominant Polycystic Kidney Disease - A Randomized Control Trial.", "journal": "Indian J Nephrol", "authors": ["Venkatasubramanian V", "Sethi J", "Kumar V", "Yadav AK", "Lal A", "Kohli HS"], "date": "2025-05-01T00:00:00Z", "doi": "10.25259/IJN_100_2024", "meta_date_publication": "2025 May-Jun", "meta_volume": "35", "meta_issue": "3", "meta_pages": "410-416", "score": 50248.062, "text_hl": "Baseline characteristics were distributed equally across randomized groups. Baseline @<m>DISEASE_Proteinuria</m> @DISEASE_MESH:D011507 @@@proteinuria@@@ was significantly higher in the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ arm (p = 0.014). ", "citations": {"NLM": "Venkatasubramanian V, Sethi J, Kumar V, Yadav AK, Lal A, Kohli HS. Metformin Versus Standard of Care in Patients with Autosomal Dominant Polycystic Kidney Disease - A Randomized Control Trial. Indian J Nephrol. 2025 May-Jun;35(3):410-416. PMID: 40352872", "BibTeX": "@article{40352872, title={Metformin Versus Standard of Care in Patients with Autosomal Dominant Polycystic Kidney Disease - A Randomized Control Trial.}, author={Venkatasubramanian V and Sethi J and Kumar V and Yadav AK and Lal A and Kohli HS}, journal={Indian J Nephrol}, volume={35}, number={3}, pages={410-416}}"}}, {"_id": "31904843", "pmid": 31904843, "title": "Metformin enhances the immunomodulatory potential of adipose-derived mesenchymal stem cells through STAT1 in an animal model of lupus.", "journal": "Rheumatology (Oxford)", "authors": ["Jang SG", "Lee J", "Hong SM", "Kwok SK", "Cho ML", "Park SH"], "date": "2020-06-01T00:00:00Z", "doi": "10.1093/rheumatology/kez631", "meta_date_publication": "2020 Jun 1", "meta_volume": "59", "meta_issue": "6", "meta_pages": "1426-1438", "score": 50247.48, "text_hl": "Administration of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-treated Ad-MSCs resulted in significant disease activity improvement including @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ phenotype, @DISEASE_Glomerulonephritis @DISEASE_MESH:D005921 @@@glomerulonephritis@@@, @<m>DISEASE_Proteinuria</m> @DISEASE_MESH:D011507 @@@proteinuria@@@ and anti-dsDNA IgG antibody production in @CELLLINE_CVCL:B6HA @@@MRL/lpr@@@ @SPECIES_10090 @@@mice@@@. ", "citations": {"NLM": "Jang SG, Lee J, Hong SM, Kwok SK, Cho ML, Park SH. Metformin enhances the immunomodulatory potential of adipose-derived mesenchymal stem cells through STAT1 in an animal model of lupus. Rheumatology (Oxford). 2020 Jun 1;59(6):1426-1438. PMID: 31904843", "BibTeX": "@article{31904843, title={Metformin enhances the immunomodulatory potential of adipose-derived mesenchymal stem cells through STAT1 in an animal model of lupus.}, author={Jang SG and Lee J and Hong SM and Kwok SK and Cho ML and Park SH}, journal={Rheumatology (Oxford)}, volume={59}, number={6}, pages={1426-1438}}"}}, {"_id": "37498548", "pmid": 37498548, "title": "Metformin reduces insulin resistance and attenuates progressive renal injury in prepubertal obese Dahl salt-sensitive rats.", "journal": "Am J Physiol Renal Physiol", "authors": ["Ekperikpe US", "Mandal S", "Holt SJ", "Daniels JK", "Johnson TD", "Cooper JS", "Safir SM", "Cornelius DC", "Williams JM"], "date": "2023-07-27T00:00:00Z", "doi": "10.1152/ajprenal.00078.2023", "meta_date_publication": "2023 Jul 27", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50247.42, "text_hl": "@<m>DISEASE_Proteinuria</m> @DISEASE_MESH:D011507 @@@Proteinuria@@@ was significantly greater in SSLepRmutant rats versus SS rats throughout the study, and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ administration significantly reduced @<m>DISEASE_Proteinuria</m> @DISEASE_MESH:D011507 @@@proteinuria@@@ in SSLepRmutant rats. ", "citations": {"NLM": "Ekperikpe US, Mandal S, Holt SJ, Daniels JK, Johnson TD, Cooper JS, Safir SM, Cornelius DC, Williams JM. Metformin reduces insulin resistance and attenuates progressive renal injury in prepubertal obese Dahl salt-sensitive rats. Am J Physiol Renal Physiol. 2023 Jul 27;():. PMID: 37498548", "BibTeX": "@article{37498548, title={Metformin reduces insulin resistance and attenuates progressive renal injury in prepubertal obese Dahl salt-sensitive rats.}, author={Ekperikpe US and Mandal S and Holt SJ and Daniels JK and Johnson TD and Cooper JS and Safir SM and Cornelius DC and Williams JM}, journal={Am J Physiol Renal Physiol}}"}}, {"_id": "32774367", "pmid": 32774367, "pmcid": "PMC7396103", "title": "Clinical Characteristics and Prevalence of Comorbidities according to Metformin Use in Korean Patients with Type 2 Diabetes", "journal": "Int J Endocrinol", "authors": ["Chin SO", "Ha IG", "Rhee SY", "Jeong SJ", "Chon S", "Kim SH", "Ahn KJ", "Baik SH", "Park Y", "Nam MS", "Lee KW", "Woo JT"], "date": "2020-07-24T00:00:00Z", "doi": "10.1155/2020/9879517", "meta_date_publication": "2020", "meta_volume": "2020", "meta_issue": "", "meta_pages": "9879517", "score": 50246.33, "text_hl": "Tables 4 and 5 show the prevalence of macro- and microvascular complications of @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ according to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use. While no significant difference was observed in macrovascular complications according to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use (Table 4), the prevalence of @DISEASE_Diabetic_Retinopathy @DISEASE_MESH:D003930 @@@diabetic retinopathy@@@, @DISEASE_Cataract @DISEASE_MESH:D002386 @@@cataracts@@@, overt @<m>DISEASE_Proteinuria</m> @DISEASE_MESH:D011507 @@@proteinuria@@@, @DISEASE_Renal_Insufficiency @DISEASE_MESH:D051437 @@@renal insufficiency@@@ (estimated glomerular filtration rate < 60 mL/min/1.73 m2), and @DISEASE_Peripheral_Nervous_System_Diseases @DISEASE_MESH:D010523 @@@peripheral neuropathy@@@ was lower in the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ user group (Table 5). ", "citations": {"NLM": "Chin SO, Ha IG, Rhee SY, Jeong SJ, Chon S, Kim SH, Ahn KJ, Baik SH, Park Y, Nam MS, Lee KW, Woo JT. Clinical Characteristics and Prevalence of Comorbidities according to Metformin Use in Korean Patients with Type 2 Diabetes Int J Endocrinol. 2020;2020():9879517. PMID: 32774367", "BibTeX": "@article{32774367, title={Clinical Characteristics and Prevalence of Comorbidities according to Metformin Use in Korean Patients with Type 2 Diabetes}, author={Chin SO and Ha IG and Rhee SY and Jeong SJ and Chon S and Kim SH and Ahn KJ and Baik SH and Park Y and Nam MS and Lee KW and Woo JT}, journal={Int J Endocrinol}, volume={2020}, pages={9879517}}"}}]}